Disease: Thyroid cancer- anaplastic
- (Pentamethylcyclopentadienyl)chloridoiridium(III) Complex Bearing Bidentate Ph<sub>2</sub>PCH<sub>2</sub>CH<sub>2</sub>SPh-κ<em>P</em>,κ<em>S</em> Ligand
- <em>Correction to</em>: Factors Associated with Survival in Anaplastic Thyroid Carcinoma: A Multicenter Study from the ENDOCAN-TUTHYREF Network by Jannin et al. Thyroid 2023;33(10):1190-1200; doi: 10.1089/thy.2023.0164
- A case of tracheal stenosis due to anaplastic thyroid carcinoma treated using the stent-in-stent method
- A phase II study of encorafenib in combination with binimetinib in patients with metastatic BRAF-mutated thyroid cancer in Japan
- A Pyroglutamate Aminopeptidase 1 Responsive Fluorescence Imaging Probe for Real-Time Rapid Differentiation between Thyroiditis and Thyroid Cancer
- A Rare Case of NUT Carcinoma of the Thyroid
- A zebrafish xenotransplant model of anaplastic thyroid cancer to study the tumor microenvironment and innate immune cell interactions in vivo
- Accuracy of World Health Organisation-grade parameters (necrosis and mitotic activity) and foci of vascular invasion in predicting prognosis of papillary thyroid carcinoma. A case-control validation study
- Alginate/carboxymethyl chitosan core-shell microspheres co-loaded with docetaxel/doxorubicin reverse chemotherapy resistance in anaplastic thyroid carcinoma
- Alginate/Carboxymethyl Chitosan Core-Shell Microspheres Coloaded with Doxorubicin/Docetaxel Reverse Chemotherapy Resistance in Anaplastic Thyroid Carcinoma
- An Era of Advances in Systemic Therapies for Advanced Thyroid Cancer
- Anaplastic and poorly differentiated thyroid carcinomas: genetic evidence of high-grade transformation from differentiated thyroid carcinoma
- Anaplastic thyroid cancer spheroids as preclinical models to test therapeutics
- Anaplastic Thyroid Carcinoma With Air Spaces
- Anaplastic Transformation in Papillary Thyroid Carcinoma: A Case Report
- Autophagy sustains mitochondrial respiration and determines resistance to BRAF(V600E) inhibition in thyroid carcinoma cells
- BUB1/KIF14 complex promotes anaplastic thyroid carcinoma progression by inducing chromosome instability
- Challenging Case of Anaplastic Thyroid Cancer With Unusual Clinical and Histological Features: A Diagnostic Dilemma With Undifferentiated Pleomorphic Sarcoma
- Changes in the diagnosis of thyroid tumours in the 5th edition of the WHO classification of endocrine neoplasms
- Checkpoint Inhibition in Addition to Dabrafenib/Trametinib for BRAF<sup>V600E</sup> Mutated Anaplastic Thyroid Carcinoma
- Circulating immunophenotypes are potentially prognostic in follicular cell-derived thyroid cancer
- Clinicopathologic Features and Cytologic Correlation of ALK-Rearranged Papillary Thyroid Carcinoma: A Series of Eight Cases
- Combination of Dabrafenib and Trametinib in Patients with Metastatic BRAFV600E-Mutated Thyroid Cancer
- Combinatorial Hypofractionated Radiotherapy and Pembrolizumab in Anaplastic Thyroid Cancer
- Comparative study between poorly differentiated thyroid cancer and anaplastic thyroid cancer: real-world pathological distribution, death attribution, and prognostic factor estimation
- Concurrent Anaplastic and Papillary Thyroid Carcinoma Manifesting as a Thyrocutaneous Fistula
- Current and future of immunotherapy for thyroid cancer based on bibliometrics and clinical trials
- Current evidences in poorly differentiated thyroid carcinoma: a systematic review and subsection meta-analysis for clinical decision making
- Development and validation of a nomogram to predict overall survival in patients with redefined anaplastic thyroid carcinoma based on the SEER database
- Disrupting glycolysis and DNA repair in anaplastic thyroid cancer with nucleus-targeting platinum nanoclusters
- Distinct tumor microenvironment makes anaplastic thyroid cancer more lethal but immunotherapy-sensitive than papillary thyroid cancer
- Drug-induced inhibition of HMGA and EZH2 activity as a possible therapy for anaplastic thyroid carcinoma
- Effectiveness of prognostic nutritional index in predicting overall survival and evaluating immunotherapy response in anaplastic thyroid carcinoma
- ENO2 promotes anoikis resistance in anaplastic thyroid cancer by maintaining redox homeostasis
- Evaluation of the Therapeutic Effects of Harmine on Anaplastic Thyroid Cancer Cells
- First effectiveness data of lenvatinib and pembrolizumab as first-line therapy in advanced anaplastic thyroid cancer: a retrospective cohort study
- FOXE1 Gene is a Probable Tumor Suppressor Gene with Decreased Expression as Papillary Thyroid Cancers Grow, and is Absent in Anaplastic Thyroid Cancers
- Ga-68 Prostate-specific Membrane Antigen-HBED-CC Positron Emission Tomography-Computed Tomography in Anaplastic Thyroid Carcinoma
- Genetic alterations in thyroid cancer mediating both resistance to BRAF inhibition and anaplastic transformation
- Genetic landscape of 482 thyroid carcinomas: analysis with the national datacenter for cancer genomic medicine in Japan
- Genomic landscape and clinical features of advanced thyroid carcinoma: a national database study in Japan
- Geriatric Importance of Histopathological Parameters Evaluated in Thyroidectomy Specimens: A Single Center Retrospective Analysis
- Harnessing Immunity to Treat Advanced Thyroid Cancer
- High Malignancy Risk and Its Predictors in South Indian Patients With Bethesda II Thyroid Nodules
- Honokiol Suppresses Cell Proliferation and Tumor Migration through ROS in Human Anaplastic Thyroid Cancer Cells
- Identification of invasive subpopulations using spatial transcriptome analysis in thyroid follicular tumors
- Identification of potential targetable genes in papillary, follicular, and anaplastic thyroid carcinoma using bioinformatics analysis
- Immunotherapy for endocrine tumours : a clinician's perspective
- Immunotherapy for endocrine tumours: a clinician's perspective
- Incorporating Network Pharmacology and Experimental Validation to Identify Bioactive Compounds and Potential Mechanisms of Digitalis in Treating Anaplastic Thyroid Cancer
- Integrated analysis of transcriptome data revealed MMP3 and MMP13 as critical genes in anaplastic thyroid cancer progression
- Knowledge mapping of anaplastic thyroid cancer treatments: a bibliometric analysis (2000-2023)
- Leveraging molecular targeted drugs and immune checkpoint inhibitors treat advanced thyroid carcinoma to achieve thyroid carcinoma redifferentiation
- Long-Term Survival of a Patient With Anaplastic Thyroid Carcinoma Treated With Hypofractionated Radiotherapy: A Case Report
- Macrophage-induced carboxypeptidase A4 promotes the progression of anaplastic thyroid cancer
- Major improvement in thyroid cancer survival of elderly patients in the Nordic countries
- Mechanisms of vemurafenib-induced anti-tumor effects in ATC FRO cells
- miR-182 Promotes Tumor Growth and Increases Chemoresistance of Human Anaplastic Thyroid Cancer by Targeting Tripartite Motif 8 [Retraction]
- Molecular Pathology of Thyroid Tumors: Essential Points to Comprehend Regarding the Latest WHO Classification
- Molecular Targeting of the BRAF Proto-Oncogene/Mitogen-Activated Protein Kinase (MAPK) Pathway across Cancers
- New strategy for intraoperative phonosurgical management of recurrent laryngeal nerve infiltrated by thyroid carcinoma
- Nomogram predicts risk and prognostic factors for lung metastasis of anaplastic thyroid carcinoma: a retrospective study in the Surveillance Epidemiology and End Results (SEER) database
- Non-papillary thyroid carcinoma diagnoses in The Bethesda System for Reporting Thyroid Cytopathology categories V and VI: An institutional experience
- Papillary Thyroid Carcinoma within a Thyroglossal Cyst: A Rare Case Report with Review of Literature
- Patient with mediastinal carcinoma of unknown primary with RET fusion achieves durable response with RET inhibition
- PFKFB3 facilitates cell proliferation and migration in anaplastic thyroid carcinoma via the WNT/beta-catenin signaling pathway
- Poorly differentiated thyroid cancer: Clinical, pathological, mutational, and outcome analysis
- Poorly differentiated thyroid carcinoma: molecular, clinico-pathological hallmarks and therapeutic perspectives
- Poorly differentiated thyroid carcinomas: conceptual controversy and clinical impact
- Positron Emission Tomography/Computed Tomography in Thyroid Cancer: An Updated Review
- Progress in diagnosing and treating thyroid squamous cell carcinoma under the 5th edition of WHO classification
- Promising Approaches in Plant-Based Therapies for Thyroid Cancer: An Overview of In Vitro, In Vivo, and Clinical Trial Studies
- RAF inhibitor re-challenge therapy in BRAF-aberrant pan-cancers: the RE-RAFFLE study
- Rare Thyroid Diseases Mimicking or Concealing Primitive Thyroid Neoplasms: A Call for a "Check and Double-Check" Clinical Mindset
- Regulation of iodine-glucose flip-flop in SW1736 anaplastic thyroid cancer cell line
- Research progress of immunotherapy against anaplastic thyroid cancer
- Research progress on anaplastic thyroid carcinoma
- Retracted: Recognition of Key Genes in Human Anaplastic Thyroid Cancer via the Weighing Gene Coexpression Network
- Ruxolitinib induces apoptosis and pyroptosis of anaplastic thyroid cancer via the transcriptional inhibition of DRP1-mediated mitochondrial fission
- Selective inhibition of DNA ligase IV provides additional efficacy to the treatment of anaplastic thyroid cancer
- Should there be a paradigm shift for the evaluation of isthmic thyroid nodules?
- SIRT7 promotes the proliferation and migration of anaplastic thyroid cancer cells by regulating the desuccinylation of KIF23
- Surgery combined with adjuvant radiation and chemotherapy prolonged overall survival in stage IVC anaplastic thyroid cancer: a SEER-based analysis
- Synergistic effects of the combination of trametinib and alpelisib in anaplastic thyroid cancer with BRAF and PI3KCA co-mutations
- Targeting DEP domain containing 1 in anaplastic thyroid carcinoma: Implications for stemness regulation and malignant phenotype suppression
- Targeting PEAK1 sensitizes anaplastic thyroid carcinoma cells harboring BRAF(V600E) to Vemurafenib by Bim upregulation
- Targeting PEAK1 sensitizes anaplastic thyroid carcinoma cells harboring BRAF<sup>V600E</sup> to Vemurafenib by Bim upregulation
- Targeting PEAK1 sensitizes anaplastic thyroid carcinoma cells harboring BRAFV600E to Vemurafenib by Bim upregulation
- Targeting SIGLEC15 as an emerging immunotherapy for anaplastic thyroid cancer
- The Effect of Radioiodine Therapy on the Prognosis of Differentiated Thyroid Cancer with Lung Metastases
- The genomic and evolutionary landscapes of anaplastic thyroid carcinoma
- The role of targeted therapy and/or immunotherapy therapy in anaplastic thyroid carcinoma
- The value of multimodal treatment in anaplastic thyroid cancer patients with distant metastasis
- Theranostics of Thyroid Cancer
- Thyroid Cancer With Cutaneous Metastases
- Thyroid Cancer: A Review
- Thyroid nodules with DICER1 mutation or PTEN alteration: A comparative cytologic, clinical, and molecular study of 117 FNA cases
- Tumor microenvironment in thyroid cancer: Immune cells, patterns, and novel treatments
- Tyrosine kinase inhibitors in patients with advanced anaplastic thyroid cancer: an effective analysis based on real-world retrospective studies
- Update on current diagnosis and management of anaplastic thyroid carcinoma